Yellow fever natural history: Difference between revisions

	Yellow fever Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Yellow Fever from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Future or Investigational Therapies
Treatment
Case #1
Yellow fever natural history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Yellow fever natural history All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Yellow fever natural history
CDC on Yellow fever natural history
Yellow fever natural history in the news
Blogs on Yellow fever natural history
Directions to Hospitals Treating Yellow fever
Risk calculators and risk factors for Yellow fever natural history

Revision as of 16:23, 22 December 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

In its mildest form, yellow fever is a self-limited infection characterized by sudden onset of fever and headache without other symptoms.
Other patients experience an abrupt onset of a high fever (up to 104°F [40°C]), chills, severe headache, generalized myalgias, lumbosacral pain, anorexia, nausea, vomiting, and dizziness.
The patient appears acutely ill, and examination might demonstrate bradycardia in relation to the elevated body temperature (Faget's sign).
The patient is usually viremic during this period, which lasts for approximately 3 days.
Many patients have an uneventful recovery, but in approximately 15% of infected persons, the illness recurs in more severe form within 48 hours following the viremic period. Symptoms include fever, nausea, vomiting, epigastric pain, jaundice, renal insufficiency, and cardiovascular instability. Viremia generally is absent during this phase of symptom recrudescence.
A bleeding diathesis can occur, with hematemesis, melena, metrorrhagia, hematuria, petechiae, ecchymoses, epistaxis, and oozing blood from the gingiva and needle-puncture sites.

The possible complications are:

The majority of infected persons will be asymptomatic or have mild disease with complete recovery. ^[1]
In persons who become symptomatic but recover, weakness and fatigue may last several months.
Among those who develop severe disease, 20% - 50% may die.
Those who recover from yellow fever generally have lasting immunity against subsequent infection.

@@ Line 27: / Line 27: @@
 ===Prognosis===
-Historical reports have claimed a mortality rate of between 1 in 17 (5.8%) and 1 in 3 (33%).<ref name =Virginia>{{cite web|url=http://etext.lib.virginia.edu/etcbin/fever-browse?id=N2659002 |title= Mosquito control ends fatal plague of Yellow Fever|accessdate = 2007-06-11 |author=Mauer HB |accessyear=2006 |publisher=etext.lib.virginia.edu}} (undated newspaper clipping)</ref> The [[WHO]] factsheet on yellow fever, updated in 2001, states that 15% of patients enter a "toxic phase" and that half of that number die within ten to fourteen days, with the other half recovering.<ref name=WHOfactsheet>{{cite web |title = WHO Yellow Fever Fact Sheet |url=http://www.who.int/mediacentre/factsheets/fs100/en/ | accessdate = 2007-02-22 }}</ref>
+*The majority of infected persons will be asymptomatic or have mild disease with complete recovery. <ref> {{cite web|url=http://www.cdc.gov/yellowfever/symptoms/index.html| title=CDC Yellow Fever Symptoms and Treatment}}</ref>
+*In persons who become symptomatic but recover, weakness and fatigue may last several months.
+*Among those who develop severe disease, 20% - 50% may die.
+*Those who recover from yellow fever generally have lasting immunity against subsequent infection.
 ==References==